n-(((4-benzoylamino)phenyl)sulfonyl)glycine and Alloxan Diabetes

n-(((4-benzoylamino)phenyl)sulfonyl)glycine has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aukunuru, JV; Ayalasomayajula, SP; Clark, RC; DeRuiter, J; Kompella, UB; Sunkara, G	1

Other Studies

1 other study(ies) available for n-(((4-benzoylamino)phenyl)sulfonyl)glycine and Alloxan Diabetes

Article	Year
A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications. Pharmaceutical research, 2002, Volume: 19, Issue:3 Topics: Absorbable Implants; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Delivery Systems; Endothelial Growth Factors; Enzyme Inhibitors; Glycine; Humans; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Retina; Sulfones; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002

Article

Year

A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Pharmaceutical research, 2002, Volume: 19, Issue:3

Topics: Absorbable Implants; Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Delivery Systems; Endothelial Growth Factors; Enzyme Inhibitors; Glycine; Humans; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Retina; Sulfones; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002